A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283
Roisin E. O'Cearbhaill, Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah DeLair, Sheila Segura, Shweta Chavan, Dmitriy Zamarin, Robert DeBernardo, Kathleen Moore, John Moroney, Mark Shahin, Premal H. Thaker, Andrea E. Wahner-Hendrickson, Carol Aghajanian
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283'. Together they form a unique fingerprint.